NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Allegheny Technologies (ATI) was downgraded at JP Morgan from overweight to neutral. $29 price target. Estimates also cut, given the oversupply in the stainless steel market, JP Morgan said.
Cubist Pharmaceuticals (CBST) was initiated with a sell rating at Cantor Fitzgerald. $37 price target. Cubicin growth will likely slow in 2013, Cantor said.Cullen/Frost (CFR) was upgraded at Sterne Agee from underperform to neutral. Valuation call, based on a $54 price target, Sterne Agee said. Ciena (CIEN - Get Report) was upgraded at FBR Capital Markets from market perform to outperform. Company can gain market share in the coming quarters, FBR Capital Markets said. Crocs (CROX - Get Report) was downgraded at Sterne Agee from buy to neutral. Estimates were also cut, given the company's new guidance, Sterne Agee said. F5 Networks (FFIV - Get Report) was downgraded at Wunderlich from buy to hold. $100 price target. Company posted lower earnings and is leveraged to slower macro growth, Wunderlich said. LSI (LSI) was downgraded at Wedbush from outperform to neutral. $7 price target. Company is seeing lower flash demand, Wedbush said. NY Community Bancorp (NYB) was downgraded at Keefe, Bruyette & Woods from outperform to market perform. $13.50 price target. Net interest margin is declining and the company lacks near-term visibility, KBW said. Prosperity Bancshares (PB) was upgraded at KBW from market perform to outperform. $48 price target. American State deal will add to earnings, KBW said. Wyndham (WYN) was downgraded at Deutsche Bank from buy to hold. Valuation call, based on a $57 price target, Deutsche Bank said. Zynga (ZNGA - Get Report) was upgraded at Needham from hold to buy. Valuation call, based on a $4 price target, Needham said. Company has a solid cash cushion, Needham added.
STOCK COMMENTS / EPS CHANGESBest Buy (BBY) numbers were cut at UBS. Shares are now seen reaching $18. Estimates were also lowered following preannouncement, UBS said. Neutral rating. Cheesecake Factory (CAKE) numbers were reduced at Lazard. Shares are now seen reaching $39. Estimates were also cut, given lower expected store growth, Lazard said. Buy rating.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts